Back to library
Loading…
cognition · The Lancet Neurology · 2018
This study elucidated the progression of Alzheimer's disease biomarkers and clinical symptoms in adults with Down syndrome, highlighting key stages of cognitive decline.
Strydom, André; Coppus, Annelies M; Bussi, Carole; Bulley, Sara; Dean, John; Head, Elizabeth; King, Robert; Lott, Ira T; Mansour, Sameer; Mok, Ka Ming; Startin, Cathryn M; Tournay, André; Tybulewicz, Victor; Vaitheswaran, Sowmya; Zaman, Sha
This study elucidated the progression of Alzheimer's disease biomarkers and clinical symptoms in adults with Down syndrome, highlighting key stages of cognitive decline.